D.E. Shaw & Co’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $672K | Buy |
+59,771
| New | +$672K | ﹤0.01% | 2408 |
|
|
2025
Q1 | – | Sell |
-546,418
| Closed | -$5.37M | – | 3101 |
|
|
2024
Q4 | $5.37M | Sell |
546,418
-326,233
| -37% | -$3.2M | ﹤0.01% | 1263 |
|
|
2024
Q3 | $7.11M | Buy |
872,651
+438,742
| +101% | +$3.58M | 0.01% | 1116 |
|
|
2024
Q2 | $5.8M | Buy |
433,909
+431,780
| +20,281% | +$5.77M | 0.01% | 1198 |
|
|
2024
Q1 | $98.8K | Sell |
2,129
-7,880
| -79% | -$366K | ﹤0.01% | 2827 |
|
|
2023
Q4 | $677K | Buy |
10,009
+9,740
| +3,621% | +$658K | ﹤0.01% | 2252 |
|
|
2023
Q3 | $19.5K | Buy |
+269
| New | +$19.5K | ﹤0.01% | 2808 |
|
|
2023
Q2 | – | Sell |
-270
| Closed | -$14.4K | – | 3149 |
|
|
2023
Q1 | $14.4K | Sell |
270
-390
| -59% | -$20.8K | ﹤0.01% | 3088 |
|
|
2022
Q4 | $44.6K | Buy |
+660
| New | +$44.6K | ﹤0.01% | 3206 |
|
|
2022
Q3 | – | Sell |
-285
| Closed | -$27K | – | 3955 |
|
|
2022
Q2 | $27K | Sell |
285
-55,009
| -99% | -$5.21M | ﹤0.01% | 3770 |
|
|
2022
Q1 | $8.91M | Buy |
55,294
+48,137
| +673% | +$7.76M | 0.01% | 1194 |
|
|
2021
Q4 | $2.38M | Sell |
7,157
-15,198
| -68% | -$5.05M | ﹤0.01% | 2269 |
|
|
2021
Q3 | $10.4M | Buy |
+22,355
| New | +$10.4M | 0.01% | 1019 |
|